Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorCentre Hospitalier Esquirol

About this trial

This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.

The study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Gender and Age: Male or female, aged 18 to 65

Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria

Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol

Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).

Disqualifiers

Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)

History of Eating Disorder other than current disorder

Proven sensory or neurological disability

Inability to understand questionnaires and information related to the study

Trial population

Participants will be enrolled during hospitalization or consultation of their Eating Disorder treatment in the Esquirol Hospital Center of Limoges, France.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Scales

    Other intervention

    Five questionnaires were administered at inclusion, socio-demographic and clinical data were collected during an interview (anxiety-depression, treatments). The following questionnaires were used: The Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr), the Eating Disorder Examination Self-Report Questionnaire (EDE-Q), the Adolescent/Adult Sensory Profile (AASP), the Coping Inventory for Stressful Situations (CISS), the Hospital anxiety and depression scale (HAD) and the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2).

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Sensory profile from the Adolescent and Adult Sensory Profile (Brown and Dunn, 2002) according to each diagnostic group.

Sensory profile scores will be obtained using the Adolescent and Adult Sensory Profile (AASP) scale during an individual interview after the participant has been included in the study. Subscores for sensory sensitivity, low registration, sensation seeking, and sensation avoidance will be collected. For each subscore, the minimum and maximum values range from 15 to 75. A high score indicates high sensory sensitivity.

Time frame
At enrollment
2

Scores for task coping drawn from the Coping Inventory for Stressful Situations (Endler & Parker, adapted by JP Rolland) according to each diagnostic group

Coping scores will be obtained using the Coping Inventory for Stressful Situations (CISS) scale during an individual interview after the participant has been included in the study. The task-oriented coping subscore, emotion subscore, avoidance subscore, distraction subscore, and social diversion subscore will be collected. The minimum and maximum values range from 16 to 90. A high score indicates high oriented coping.

Time frame
at enrollment

Secondary outcomes

1

Description of the frequency of autistic traits for each diagnostic group

The frequency of autistic traits will be obtained using the Revised Ritvo Autism and Asperger Diagnostic Scale (RAADS-R-Fr) during an individual interview after the participant has been included in the study. The minimum and maximum values range from 0 to 240. The generally accepted threshold for significant autistic traits is 70. A high score indicate high autistic traits.

Time frame
At enrollment
2

Description of the frequency of eating disorders for each diagnostic group.

Eating disorders will be assessed using the Eating Disorder Examination Self-Report Questionnaire (EDE-Q) during an individual interview after the participant's inclusion. The EDE-Q, provide subscale scores reflecting the severity of aspects of the psychopathology of eating disorders. The subscales are Restraint, Eating Concern, Shape Concern and Weight Concern. For Restaint subscale minimum and maximum values range from 0 to 30. For Eating Concern subscale minimum and maximum values range from 0 to 30. For Shape Concern subscale minimum and maximum values range from 0 to 48. For Weight Concern subscale minimum and maximum values range from 0 to 30. The higher the score, the more severe the symptoms.

Time frame
At enrollment
3

Anxiety according to each diagnostic group.

Anxiety and depression will be obtained using the Hospital Anxiety and Depression Scale (HAD) during an individual interview after the participant's inclusion. The anxiety subscore will be collected. Minimum and maximum values range from 0 to 21. The generally accepted threshold for significant anxiety is 11.

Time frame
At enrollment
4

Body awareness from the multidimensional assessment of interoceptive awareness for each diagnostic group.

Body awareness will be obtained using the Multidimensional Assessment of Interoceptive Awareness Version 2 (MAIA-2) scale during an individual interview after the participant's inclusion. Minimum and maximum values range from 0 to 185. A high score indicates high interoceptive awareness.

Time frame
At enrollment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: